Anakinra is an IL-1 receptor antagonist that has been implicated in the treatment of HS because of the noted elevated levels of this inflammatory cytokine and is also used in the management of AIDs owing to the role of IL-1 as a pro-inflammatory agent in this spectrum of diseases as well106. Here, IL1B is linked to histiocytic sarcoma.